Status:
UNKNOWN
Observational and Prospective Study of Hepatic Steatosis and Related Risk Factors Using Ultrasound and Artificial Intelligence
Lead Sponsor:
University of Bari
Collaborating Sponsors:
Eurisko Technology srl
Centro Radiologico Lucano
Conditions:
Liver Steatoses
Eligibility:
All Genders
18-70 years
Brief Summary
Fatty liver is the most frequent chronic liver disease worldwide and ultrasonography is widely employed for diagnosis. The accuracy of this technique, however, is strongly operator-dependent. Few info...
Detailed Description
In recent years, ultrasound has taken on a predominant role in the evaluation of liver steatosis, as it is a non-invasive, non-irradiating method that is easily reproducible and inexpensive. Of partic...
Eligibility Criteria
Inclusion
- Age between 18-70 years
- MRI regardless of clinical indications,
- written informed consent
Exclusion
- cirrhosis
- hepatocellular carcinoma or any liver tumours,
- absence of the right kidney
- previous liver transplantation
- large liver cysts or kidney cysts
Key Trial Info
Start Date :
January 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06103175
Start Date
January 15 2023
End Date
November 1 2024
Last Update
November 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J - Clinica medica "A. Murri"
Bari, BA, Italy, 70124